Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: Preliminary data

Annals of the Rheumatic Diseases

Volumn 64, Issue 1, 2005, Pages 144-146

  Baron M A ^a   Khamashta, M A ^a   Hughes, G R V ^a   D'Cruz, D P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARM BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEG BLOOD FLOW; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANKLE; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 11344263142     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.016204     Document Type: Article

References (14)

1. Godfrey T, D'Cruz D. Antiphospholipid syndrome: general features. In: Khamashta MA, ed. Hughes syndrome. Antiphospholipid syndrome. London: Springer, 2000:8-19.
2. Takeuchi S, Obayashi T, Toyama J. Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA. Heart 1998;79:96-8.
3. Matsuura E, Koike T. Accelerated atheroma and anti-β2-glycoprotein I antibodies. Lupus 2000;9:210-16.
4. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000;9:170-5.
5. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LC, Criqui MH, et al. Prevention conference V. Beyond secondary prevention: identifying the high-risk patients for primary prevention noninvasive tests of atherosclerotic burden, Circulation 2000;101:e16-22.
6. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop. Arthritis Rheum 1999;42:1309-11.
7. Sacks D, Bakal CW, Beatty PT, Becker GJ, Cardello JF, Raabe RD, et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease. A consensus statement developed by the standards division of the Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 2002;13:353.
8. Grundy SM, Howard B, Smith S, Eckel R, Redberg R, Bonow RO. Prevention conference VI: Diabetes and cardivoascular disease. Executive summary. Conference proceeding of healthcare professionals from a special writing group of the American Heart Association. Circulation 2002;105:2231-9.
9. Shome GP, Sakauchi M, Yamane K, Takemura H, Kashiwagi H. Ischaemic heart disease in systemic lupus erythematosus. A retrospective study of 65 patients treated with prednisone. Jpn J Med Sci Biol 1989;28:599-603.
10. Palmieri V, Tracy RP, Roman MJ, Liu JE, Best LG, Bella JN, et al. Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes. Diabetes Care 2003;26:2764-9.
11. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997;131:115-25.
12. George J, Afek A, Gilburd B, Blank M, Levy Y, Aron-Maor A, et al. Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 1998;98:1108-15.
13. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
14. Hörkkö S, Olee T, Mo L, Branch D, Woods VL, Palinski W, et al. Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta2- glycoprotein i and oxidized low-density lipoprotein. Circulation 2001;103:941-6.